Pure Global

"Bard" VIELIACE implantable injection seat - Taiwan Registration a71ba32d3413b3b883ae2ed34c6caae3

Access comprehensive regulatory information for "Bard" VIELIACE implantable injection seat in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a71ba32d3413b3b883ae2ed34c6caae3 and manufactured by BARD ACCESS SYSTEMS, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
a71ba32d3413b3b883ae2ed34c6caae3
Registration Details
Taiwan FDA Registration: a71ba32d3413b3b883ae2ed34c6caae3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Bard" VIELIACE implantable injection seat
TW: โ€œๅทดๅพทโ€ๅจๅŠ›่‰พๆ–ฏๆคๅ…ฅๅผๆณจๅฐ„ๅบง
Risk Class 2

Registration Details

a71ba32d3413b3b883ae2ed34c6caae3

DHA00602478005

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order

J General hospital and personal use equipment

J.5965 Subcutaneous implantable intravascular injection port and guide

import

Dates and Status

Mar 12, 2013

Mar 12, 2028